scispace - formally typeset
C

Charles Catton

Researcher at Princess Margaret Cancer Centre

Publications -  60
Citations -  2346

Charles Catton is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 23, co-authored 60 publications receiving 1925 citations. Previous affiliations of Charles Catton include University Health Network & University of Toronto.

Papers
More filters
Journal ArticleDOI

Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence

TL;DR: In this paper, the authors considered whether a positive margin occurring after resection of a soft-tissue sarcoma of a limb would affect the incidence of local recurrence, and they found that patients with low-grade liposarcomas were expected to be a low-risk group as were those who had positive margins planned before surgery to preserve critical structures.
Journal ArticleDOI

Cancer-related fatigue and associated disability in post-treatment cancer survivors.

TL;DR: Clinically relevant levels of CRF are present in approximately 1/3 of cancer survivors up to 6 years post-treatment, and this is associated with high levels of disability.
Journal ArticleDOI

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

TL;DR: The initial results do not support routine administration of adjuvant radiotherapy after radical prostatectomy, and an observation policy with salvage radiotherapy for PSA biochemical progression should be the current standard after radical Prostate cancer.
Journal ArticleDOI

Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation.

TL;DR: Implant quality as determined by D(90), V(100, V(200), and urethral dose did not predict AUR, but prostate volume and prior hormone use were found to be independent predictors of AUR.
Journal ArticleDOI

Stage II Testicular Seminoma: Patterns of Recurrence and Outcome of Treatment

TL;DR: In stage IIA/B seminoma, radiotherapy continues to provide excellent results, as the majority of patients will be cured with this treatment alone, and Chemotherapy is the treatment of choice for stage IIC seminoma.